DUBLIN, IRELAND / ACCESSWIRE / August 29, 2018 / On 25 April 2018, CRH plc (LSE: CRH) (NYSE: CRH) announced its intention to repurchase ordinary shares of up to €1 billion over the next 12 months.
Having completed the first phase of its share buyback programme on 31 July 2018, under which €350 million of cash was returned to shareholders, CRH today announces that it has entered into arrangements with UBS A.G., London Branch ("UBS") to repurchase ordinary shares on CRH's behalf for a maximum consideration of €350 million (the "Phase 2 Programme").
The Phase 2 Programme will commence today, 29 August 2018, and will end no later than 19 November 2018.
Under the terms of the Phase 2 Programme, ordinary shares will be repurchased on the London Stock Exchange and/or Euronext Dublin. CRH has entered into non-discretionary instructions with UBS to conduct the Phase 2 Programme on its behalf and to make trading decisions under the Phase 2 Programme independently of CRH in accordance with certain pre-set parameters.
The Phase 2 Programme, the purpose of which is to reduce the share capital of CRH, will be conducted within the limitations of the authority granted at CRH's AGM on 26 April 2018 to repurchase up to 10% of the Company's ordinary shares in issue (being 72,741,730 ordinary shares following the completion of the first phase of the buyback programme), the parameters prescribed by the Market Abuse Regulation 596/2014, the Commission Delegated Regulation (EU) 2016/1052 and Chapter 12 of the UK Listing Rules. The repurchased ordinary shares will be held in treasury pending their cancellation or re-issue in due course.
This announcement relates solely to the Phase 2 Programme and any decision in relation to any future buyback programmes will be based on an ongoing assessment of the capital needs of the business and general market conditions.
Contact CRH at Dublin 404 1000 (+353 1 404 1000)
Head of Investor Relations
Registered Office: No 12965. Registered Office: 42 Fitzwilliam Square, Dublin 2, R02 R279, Ireland
SOURCE: CRH plc